← All organizations

Relypsa

For profitContributed to NMEWebsite ↗

Also known as: Relypsa, Inc. | RELYPSA INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Jun 17, 2019

Timeline

2000s

Jan 1, 2007
Relypsa— Founded

2010s

Oct 21, 2015
patiromer— NDA Organization

Drugs by trial phase (3 distinct, 13 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

losartan

Indications

Approved for

Hyperkalemia

Studied for

Marketed drugs (1)

patiromer

Recent trials (22)

NCT03781089CollaboratorPhase 4Jun 17, 2019
NCT03888066Study directorPhase 3Apr 25, 2019
NCT03888066Lead sponsorPhase 3Apr 25, 2019
NCT03597035CollaboratorPhase 4Aug 27, 2017
NCT03087058Lead sponsorPhase 2Apr 1, 2017
NCT03087058Study directorPhase 2Apr 1, 2017
NCT03071263Lead sponsorPhase 2Feb 13, 2017
NCT03071263Study directorPhase 2Feb 13, 2017
NCT02823626CollaboratorN/ASep 1, 2016
NCT02933450CollaboratorPhase 4Aug 1, 2016
NCT02694744Study directorPhase 4Feb 1, 2016
NCT02694744Lead sponsorPhase 4Feb 1, 2016
NCT01810939Study directorPhase 3Feb 1, 2013
NCT01810939Lead sponsorPhase 3Feb 1, 2013
NCT01371747Lead sponsorPhase 2Jun 1, 2011

Details

Founded: Redwood City, CA, US Jan 1, 2007
First NDA: Oct 21, 2015
Last known activity: Jun 17, 2019